In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 30 | Yes |
Popular Name: Pravastatin Sodium Pravastatin Sodium
Find On: PubMed — Wikipedia — Google
CAS Numbers: 81093-37-0 , 81131-70-6 , [81131-70-6]
81093-37-0; C01844; Pravastatin
81093-37-0; D08410; Pravastatin (INN); Pravator (TN)
81131-70-6 (hydrochloride salt)
81131-70-6; CS-514; D00893; Pravachol (TN); Pravastatin sodium (JP16/USAN)
CPD000469187; PRAVASTATIN Sodium; 81131-70-6
CPD000469187; PRAVASTATIN Sodium; SAM001246656
Pravastatin tert-Octylamine Salt
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.15 | 6.73 | -54.29 | 3 | 7 | -1 | 127 | 423.526 | 11 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.42e-01 g/l | DrugBank-approved |
biological_use | Antihypercholesterolaemic agent | IBScreen Bioactives |
Indications | antihypercholesterolemic | KeyOrganics Bioactives |
Therapy | antihyperlipidemic, HMGCoA reductase inhibitor | SMDC Pharmakon |
UniProt Database Links | CPS2_STRCC; S22A8_RAT; SO1B1_HUMAN | ChEBI |
mechanism | HMG CoA reductase inhibitor | IBScreen Bioactives |
Target | HMG-CoA Reductase | Selleck Chemicals |
biological_use | Increases receptor-mediated catabolism of low density lipoprotein | IBScreen Bioactives IBScreen Bioactives |
biological_source | Isol. from Absidia coerulea | ZereneX Building Blocks |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP02590p; 1 Sodium | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP02590p; SALT: 1 Sodium | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HMDH-1-E | HMG-CoA Reductase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5 | 0.39 | Binding ≤ 10μM |
HMDH-1-E | HMG-CoA Reductase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 32 | 0.35 | Binding ≤ 10μM |
ERG1-2-E | Squalene Monooxygenase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 430 | 0.30 | Functional ≤ 10μM |
ERG7-2-E | Lanosterol Synthase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 430 | 0.30 | Functional ≤ 10μM |
FDFT-2-E | Squalene Synthetase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 430 | 0.30 | Functional ≤ 10μM |
Z50597-11-O | Rattus Norvegicus (cluster #11 Of 12), Other | Other | 329 | 0.30 | Functional ≤ 10μM |
Z81020-2-O | HepG2 (Hepatoblastoma Cells) (cluster #2 Of 8), Other | Other | 5100 | 0.25 | Functional ≤ 10μM |
Z81135-1-O | L6 (Skeletal Muscle Myoblast Cells) (cluster #1 Of 4), Other | Other | 7600 | 0.24 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HMDH_RAT | P51639 | HMG-CoA Reductase, Rat | 13 | 0.37 | Binding ≤ 1μM |
HMDH_HUMAN | P04035 | HMG-CoA Reductase, Human | 30 | 0.35 | Binding ≤ 1μM |
HMDH_RAT | P51639 | HMG-CoA Reductase, Rat | 13 | 0.37 | Binding ≤ 10μM |
HMDH_HUMAN | P04035 | HMG-CoA Reductase, Human | 30 | 0.35 | Binding ≤ 10μM |
Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 5100 | 0.25 | Functional ≤ 10μM |
Z81135 | Z81135 | L6 (Skeletal Muscle Myoblast Cells) | 1519 | 0.27 | Functional ≤ 10μM |
ERG7_HUMAN | P48449 | Lanosterol Synthase, Human | 430 | 0.30 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 141 | 0.32 | Functional ≤ 10μM |
ERG1_HUMAN | Q14534 | Squalene Monooxygenase, Human | 430 | 0.30 | Functional ≤ 10μM |
FDFT_HUMAN | P37268 | Squalene Synthetase, Human | 430 | 0.30 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of gene expression by SREBF (SREBP) | |
Cholesterol biosynthesis | |
PPARA activates gene expression |